We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FWRD:NASDAQForward Air Corporation Analysis

Data as of 2026-05-23 - not real-time

$8.80

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Forward Air (FWRD) is trading at $8.80, well below its 20‑day SMA of $13.85, 50‑day SMA of $16.56 and 200‑day SMA of $23.21, indicating a strong bearish price trend. The 14‑day RSI of 28.2 suggests the stock is oversold, while the MACD line sits at -3.14 with a bearish histogram, reinforcing downside momentum. Current price hovers just above the identified support level of $7.86 and far from the resistance at $23.90, limiting immediate upside potential. Volatility is extreme at 195% over the past 30 days and beta is nearly 2.0, pointing to amplified price swings relative to the market.
Fundamentally, the company reports a negative profit margin of -3.7% and a trailing EPS of -$2.92, with a debt‑to‑equity ratio exceeding 1,700%, indicating severe leverage concerns. Cash on hand ($141 M) is insufficient to offset the $2.15 B debt load, and free cash flow, though positive, is modest at $55.9 M. The price‑to‑book ratio of 3.43 and a forward PE of -34.7 imply the market is pricing in significant risk despite the “Buy” consensus from analysts. Upcoming Q1 2026 earnings could catalyze short‑term moves, but the combination of technical weakness and financial strain suggests caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators (price below all SMAs, negative MACD)
  • Oversold RSI may limit immediate downside
  • Upcoming earnings release adds uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Heavy debt burden (Debt/Equity > 1,700%)
  • Modest free cash flow versus large leverage
  • Valuation metrics (P/B 3.43, negative earnings) remain unattractive

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Sustained negative profitability and low ROE
  • High volatility and beta increasing price risk
  • Sector cyclicality and potential regulatory pressures

Key Metrics & Analysis

Financial Health

Revenue Growth-5.10%
Profit Margin-3.71%
P/E Ratio-34.7
ROE-69.13%
ROA2.10%
Debt/Equity1758.63
P/B Ratio3.4
Op. Cash Flow$62.5M
Free Cash Flow$55.9M
Industry P/E29.7

Technical Analysis

TrendBearish
RSI28.2
Support$7.86
Resistance$23.90
MA 20$13.85
MA 50$16.56
MA 200$23.21
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

Target Price$18.33
Upside/Downside108.33%
GradeOvervalued
TypeValue

Risk Assessment

Beta1.98
Volatility195.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.